IP Library Granted Patent US 12,296,528
Granted Patent B2
US 12,296,528 · App. 18/391,760 · Granted May 13, 2025

Compositions and articles for additive fabrication and methods of using the same in particle image velocimetry testing

Inventors: Kangtai Ren (Geneva, IL); Robin Papachristopoulos (Elgin, IL)
Assignee: Stratasys, Inc.
B29C64/106B33Y70/10C08F220/18C09B11/24G01P5/20B29C64/135
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,296,528
App. No.
18/391,760
Granted
May 13, 2025
Kind
B2
Abstract

Radiation curable compositions for additive fabrication processes, the components cured therefrom, and their use in particle image velocimetry testing methods are described and claimed herein. Such compositions include compounds which induce free-radical polymerization, optionally compounds which induce cationic polymerization, a filler constituent, and a light absorbing component, wherein the compositions are configured to possess certain absorbance coefficients at wavelengths commonly utilized in particle image velocimetry testing. In another embodiment, the compositions include a fluorantimony-modified compound. Such compositions may be used in particle imaging velocimetry testing methods, wherein the test object utilized is created via additive fabrication and is of a substantially homogeneous construction.

Claims (26)

1. A radiation curable composition for additive fabrication, comprising, relative to the weight of the entire composition:

(a) from 25-65 wt. % of a filler constituent;

(b) from 10-50 wt. % of a cationically polymerizable constituent;

(c) from 5-40 wt. % of a free-radically polymerizable constituent;

(d) from about 0.1 wt. % up to about 15 wt. % of a cationic photoinitiator;

(e) from about 0.1 wt. % up to about 10 wt. % of a free-radical photoinitiator; and

(f) an organic salt light absorbing component.

2. The radiation curable composition of claim 1 , wherein the organic salt light absorbing component is an organic salt, preferably an ammonium salt.

3. The radiation curable composition of claim 1 , wherein the organic salt light absorbing component is in accordance with the following formula (IV):

wherein

X and X′ represents Cl − , Br − , I − , SO 4 2− , NO 3 2− , ClO 4 − , AsF 6 − , SbF 6 − , PF 6 , BF 4 − , (CF 3 CF 2 ) 3 PF 3 − , (C 6 F 5 ) 4 B − , ((CF 3 ) 2 C 6 H 3 ) 4 B − , (C 6 F 5 ) 4 Ga − , ((CF 3 ) 2 C 6 H 3 )Ga − , trifluoromethanesulfonate, nonafluorobutanesulfonate, methanesulfonate, butanesulfonate, benzenesulfonate, or p-toluenesulfonate; R 1 , R 2 , R 3 , R 1 , R 5 and R 6 each independently represent a hydrogen atom, a substituted methyl or alkyl group, or an un-substituted methyl or alkyl group; and R7 represents a hydrogen atom, an un-substituted phenyl group, or a substituted phenyl group.

4. The radiation curable composition of claim 3 , wherein X or X′ represents Cl − , Br − , I − , SO 4 2− , NO 3 − , ClO 4 − , AsF 6 − , SbF 6 − , or PF 6 − , preferably wherein X or X′ represents a hexafluoroantimony (SbF 6 ) 31 ion.

5. The radiation curable composition of claim 3 , wherein the cationic photoinitiator further comprises an anion, wherein the anion is also defined by X or X′.

6. The radiation curable composition of claim 3 , wherein the anion of the cationic photoinitiator possesses a moiety that is identical to the moiety of X or X′ in the light absorbing component.

7. The radiation curable composition of claim 1 , wherein the light absorbing component comprises a fluoroantimony counterion, and further wherein the light absorbing compound is different from (d).

8. The radiation curable composition of claim 1 , further comprising a pigment.

9. The radiation curable composition of claim 1 , wherein the filler constituent comprises a plurality of organic or inorganic microparticles or nanoparticles.

10. The radiation curable composition of claim 1 , wherein the filler constituent consists of a combination inorganic microparticles and inorganic nanoparticles.

11. The radiation curable composition of claim 1 , wherein the filler constituent consists essentially of a combination inorganic microparticles and inorganic nanoparticles.

12. The radiation curable composition of claim 11 , wherein a weight ratio of the inorganic microparticles to the inorganic nanoparticles is from 1:1 to 12:1.

13. The radiation curable composition of claim 11 , wherein the inorganic microparticles and the inorganic nanoparticles possess an average size, wherein a ratio of the average particle size of the inorganic microparticles to the average particle size of the inorganic nanoparticles is from 2.41:1 to less than 200:1, or from 2.41:1 to 100:1, or from 6.46:1 to less than 200:1, or from 6.46:1 to 100:1, wherein the average particle size of the inorganic microparticles and the inorganic nanoparticles is determined by ISO 13320:2009.

14. The radiation curable composition of claim 11 , wherein the average particle size of the inorganic nanoparticles is from 50 nanometers (nm) to 200 nm, or from 50 to 100 nm.

15. The radiation curable composition of claim 11 , wherein the average particle size of the inorganic microparticles is from 2 microns to 8 microns.

16. The radiation curable composition of claim 1 , further comprising from 0.001 wt. % to 0.5 wt. % of a stabilizer.

17. The radiation curable composition of claim 7 , wherein a fluoroantimony-modified compound is an SbF 6 -modified laser dye, or a modified triarylmethane cationic dye from a cyclic lactone precursor.

18. The radiation curable composition of claim 1 , further comprising from 5 wt. % to 15 wt. % of an oxetane.

Continuity (5)
Continuation 17502631 · Oct 15, 2021
Continuation 16957820
Provisional Application 62612157 · Dec 29, 2017
Provisional Application 62619439 · Jan 19, 2018
Related Publication 20240157627A1 · May 16, 2024
References Cited (53)
US 3708499A · Andree et al. · 1973 [cited by applicant]
US 3767358A · Stryker · 1973 [cited by applicant]
US 3849065A · Schmeidl · 1974 [cited by applicant]
US 4575330A · Hull · 1986 [cited by applicant]
US 5047568A · Angelo et al. · 1991 [cited by applicant]
US 5380923A · Wright et al. · 1995 [cited by applicant]
US 5470816A · Satake et al. · 1995 [cited by applicant]
US 5665792A · Lawton et al. · 1997 [cited by applicant]
US 6031021A · Kenny et al. · 2000 [cited by applicant]
US 6368769B1 · Ohkawa et al. · 2002 [cited by applicant]
US 7230122B2 · Liu et al. · 2007 [cited by applicant]
US 7611817B2 · Nakayashiki et al. · 2009 [cited by applicant]
US 7678528B2 · Rahman et al. · 2010 [cited by applicant]
US 8617787B2 · Suzuki et al. · 2013 [cited by applicant]
US 8953035B2 · Fukuchi et al. · 2015 [cited by applicant]
US 9228073B2 · He et al. · 2016 [cited by applicant]
US 9962142B2 · Falahatpisheh et al. · 2018 [cited by applicant]
US 11180594B2 · Ren · 2021 [cited by examiner]
US 20030149124A1 · Thommes et al. · 2003 [cited by applicant]
US 20050040562A1 · Steinmann et al. · 2005 [cited by applicant]
US 20050101684A1 · You et al. · 2005 [cited by applicant]
US 20060055088A1 · Nakayashiki et al. · 2006 [cited by applicant]
US 20060242910A1 · You · 2006 [cited by applicant]
US 20090093564A1 · Oyanagi · 2009 [cited by applicant]
US 20090182172A1 · Kolb et al. · 2009 [cited by applicant]
US 20100227941A1 · Ueda et al. · 2010 [cited by applicant]
US 20100233621A1 · Yamamoto et al. · 2010 [cited by applicant]
US 20110039205A1 · Suzuki et al. · 2011 [cited by applicant]
US 20120251829A1 · Xu et al. · 2012 [cited by applicant]
US 20120251841A1 · Southwell et al. · 2012 [cited by applicant]
US 20130070062A1 · Fouras et al. · 2013 [cited by applicant]
US 20150125702A1 · He et al. · 2015 [cited by applicant]
US 20170145184A1 · He et al. · 2017 [cited by applicant]
US 20170275414A1 · Kwisnek et al. · 2017 [cited by applicant]
US 20180264719A1 · Rolland et al. · 2018 [cited by applicant]
US 20200223992A1 · Cushen · 2020 [cited by examiner]
US 20220033553A1 · Ren et al. · 2022 [cited by applicant]
EP 1448654A1 · 2004 [cited by applicant]
EP 2218715A1 · 2010 [cited by applicant]
EP 2308865A1 · 2011 [cited by applicant]
EP 2868692A1 · 2015 [cited by applicant]
JP 2006348214A · 2006 [cited by applicant]
JP 2017036349A · 2017 [cited by applicant]
WO 2005045525A1 · 2005 [cited by applicant]
WO 2010046240A1 · 2010 [cited by applicant]
WO 2017044381A1 · 2017 [cited by applicant]
WO 2017059222A1 · 2017 [cited by applicant]
WO 2017087614A1 · 2017 [cited by applicant]
WO 2018119049A1 · 2018 [cited by applicant]
Aycock et al., “Particle image velocimetry measurements in an anatomical vascular model fabricated using inkjet 3D printing,” Experiments in Fluid, vol. 58, No. 154, 2017. [cited by applicant]
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2018/066346, mailed on Jul. 9, 2020, 10 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2018/066346, mailed on May 27, 2019, 13 pages. [cited by applicant]
Olasek et al., “Application of 3D printing technology in aerodynamic study,” Journal of Physics: Conference Series, vol. 530, 2014. [cited by applicant]